The IL6R gene polymorphisms are associated with sIL-6R, IgE and lung function in Chinese patients with asthma

被引:16
|
作者
Wang, Yajun [1 ]
Hu, Huiting [1 ]
Wu, Jun [1 ]
Zhao, Xuanna [1 ]
Zhen, Yan [1 ]
Wang, Shaobing [1 ]
Li, Wen [1 ]
Liang, Min [1 ]
Wu, Bin [1 ]
Ma, Guoda [1 ]
机构
[1] Guangdong Med Coll, Affiliated Hosp, Zhanjiang 524001, Guangdong, Peoples R China
关键词
Asthma; Polymorphisms; Rs2228145; Rs12083537; sIL-6R; IgE; SOLUBLE INTERLEUKIN-6 RECEPTOR; C-REACTIVE PROTEIN; IL-6; RECEPTOR; AIRWAY; IDENTIFICATION; INFLAMMATION; TOCILIZUMAB; INDUCTION; ELEVATION; CELLS;
D O I
10.1016/j.gene.2016.03.026
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: sIL-6R is involved in a variety of inflammatory diseases. The present study analyzed the potential associations between two IL6R gene polymorphisms (rs2228145 and rs12083537) and asthma in a Han Chinese population. Methods: A cohort of 394 patients and 395 healthy controls were genotyped to detect the two polymorphisms using SNaPshot. In 66 asthma patients and 49 controls, peripheral eosinophil and serum immunoglobulin E (IgE) levels were determined using a routine blood test, and sIL-6R levels were measured by ELISA. Results: No statistically significant differences were detected between the patients and controls in the distribution of the two independent IL6R polymorphisms (p > 0.05). However, rs2228145 C and rs12083537 G were significantly associated with decreased lung function in patients with asthma; the rs2228145 A-C variant was also associated with increased sIL-6R and IgE levels. In addition, sIL-6R levels were positively associated with IgE and inversely associated with lung function in patients with asthma. Conclusions: Our results provide evidence that rs2228145 C and rs12083537 G are associated with poor lung function in patients with asthma. Furthermore, the rs2228145 A-C variant is associated with levels of sIL-6R and IgE. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:51 / 57
页数:7
相关论文
共 50 条
  • [1] Circulating IL-6 and sIL-6R in patients with hepatocellular carcinoma
    Giannitrapani, L
    Cervello, M
    Soresi, M
    Notarbartolo, M
    La Rosa, M
    Virruso, L
    D'Alessandro, N
    Montalto, G
    HORMONE-RELATED TUMORS: NOVEL APPROACHES TO PREVENTION AND TREATMENT, 2002, 963 : 46 - 52
  • [2] The balance of interleukin (IL)-6, IL-6•soluble IL-6 receptor (sIL-6R), and IL-6•sIL-6R•sgp130 complexes allows simultaneous classic and trans-signaling
    Baran, Paul
    Hansen, Selina
    Waetzig, Georg H.
    Akbarzadeh, Mohammad
    Lamertz, Larissa
    Huber, Heinrich J.
    Ahmadian, M. Reza
    Moll, Jens M.
    Scheller, Juergen
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2018, 293 (18) : 6762 - 6775
  • [3] IL6R gene polymorphisms and their relation to chronic obstructive pulmonary disease susceptibility in the Chinese population
    Wu, Haihong
    He, Chanyi
    Fu, Yihui
    Li, Xiukuan
    Zheng, Yamei
    Mo, Rubing
    Zhang, Lei
    Zhao, Jie
    Zhang, Bingli
    Lin, Qi
    Xie, Tian
    Ding, Yipeng
    BIOMARKERS IN MEDICINE, 2022, 16 (17) : 1229 - 1237
  • [4] Correlations of IL6R gene polymorphism with pediatric asthma susceptibility
    Yu, Zongjun
    Chen, Cuizhen
    Ma, Yan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (02): : 1331 - 1336
  • [5] The Contribution of the Functional IL6R Polymorphism rs2228145, eQTLs and Other Genome-Wide SNPs to the Heritability of Plasma sIL-6R Levels
    van Dongen, Jenny
    Jansen, Rick
    Smit, Dirk
    Hottenga, Jouke-Jan
    Mbarek, Hamdi
    Willemsen, Gonneke
    Kluft, Cornelis
    Penninx, Brenda W. J.
    Ferreira, Manuel A.
    Boomsma, Dorret I.
    de Geus, Eco J. C.
    BEHAVIOR GENETICS, 2014, 44 (04) : 368 - 382
  • [6] Identification of STOML2 as a putative novel asthma risk gene associated with IL6R
    Revez, J. A.
    Matheson, M. C.
    Hui, J.
    Baltic, S.
    James, A.
    Upham, J. W.
    Dharmage, S.
    Thompson, P. J.
    Martin, N. G.
    Hopper, J. L.
    Ferreira, M. A. R.
    ALLERGY, 2016, 71 (07) : 1020 - 1030
  • [7] Therapeutic blockade of the interleukin-6 receptor (IL-6R) allows sIL-6R generation by proteolytic cleavage
    Prenissl, Niklas
    Lokau, Juliane
    Rose-John, Stefan
    Haybaeck, Johannes
    Garbers, Christoph
    CYTOKINE, 2019, 114 : 1 - 5
  • [8] The IL6R variation Asp358Ala is a potential modifier of lung function in subjects with asthma
    Hawkins, Gregory A.
    Robinson, Mac B.
    Hastie, Annette T.
    Li, Xingnan
    Li, Huashi
    Moore, Wendy C.
    Howard, Timothy D.
    Busse, William W.
    Erzurum, Serpil C.
    Wenzel, Sally E.
    Peters, Stephen P.
    Meyers, Deborah A.
    Bleecker, Eugene R.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 130 (02) : 510 - +
  • [9] The IL-6/sIL-6R complex as a novel target for therapeutic approaches
    Rose-John, Stefan
    Waetzig, Georg H.
    Scheller, Juergen
    Groetzinger, Joachim
    Seegert, Dirk
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2007, 11 (05) : 613 - 624
  • [10] The effects of anticoagulation and processing on assays of IL-6, sIL-6R, sIL-2R and soluble transferrin receptor
    DeJongh, R
    Vranken, J
    Vundelinckx, G
    Bosmans, E
    Maes, M
    Heylen, R
    CYTOKINE, 1997, 9 (09) : 696 - 701